Fig. 2: Survival of the whole cohort by the different regimens.
PFS (A) and OS (B). PFS progression-free survival, OS overall survival, PI proteasome inhibitor, dex dexamethasone, IMiD immunomodulatory drug, NR not reached.
Fig. 2: Survival of the whole cohort by the different regimens. | Blood Cancer Journal
